Ligand Pharmaceuticals Inc (NASDAQ:LGND)

106.10
Delayed Data
As of Aug 17
 -1.52 / -1.41%
Today’s Change
72.57
Today|||52-Week Range
169.98
-31.31%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Foehr Matthew William
President & Chief Operating Officer
Sale11/11/202111,160$163.02$1.8M-34.60%
Lamattina John L
Director
Sale11/16/20214,835$161.86$782.6K-34.33%
Higgins John L
Chief Executive Officer
Sale1/26/20226,183$113.68$702.9K-6.72%
Higgins John L
Chief Executive Officer
Sale11/12/20213,000$160.50$481.5K-34.30%
Foehr Matthew William
President & Chief Operating Officer
Sale1/26/20223,188$113.68$362.4K-6.72%
Higgins John L
Chief Executive Officer
Sale1/26/20223,060$113.68$347.9K-6.72%
Korenberg Matthew Edward
Sale1/26/20222,309$113.68$262.5K-6.72%
Higgins John L
Chief Executive Officer
Sale2/15/20222,061$123.68$254.9K-14.26%
Foehr Matthew William
President & Chief Operating Officer
Buy11/11/202111,160$21.92$244.6K-34.60%
Higgins John L
Chief Executive Officer
Sale2/15/20221,946$123.68$240.7K-14.26%
Page of 6